JPRN-UMIN000020009已完成未知
An explosive study on add-on effects of ribavirin in sofosbuir and ledipasvir combination therapy for patients who failed to daclatasvir and asunaprevir combination therapy. - SOF/LDV/RBV combination therapy for patients who failed to DAC/ASV therapy
Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,0 个研究点目标入组 15 人开始时间: 2015年12月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with poorly controlled cardiac disease (e.g., myocardial infarction, cardiac failure, arrhythmia) 2)Patients with severe hepatic impairment 3)Patients with a history of hypersensitivity to HCV NS5B inhibitors, Ribavirin and NS5A inhibitors 4)Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 5)Patients deemed unsuitable for study entry by their treating physician 6) Patients with renal dysfunction eGFR 50 ml/min 7)Patients who are unsuitable, in the opinion of the principal investigator, for this study due to any other reason
研究者
相似试验
未知
不适用
Efficacy and safety on effects of ribavirin with sofosbuir and ledipasvir combination therapy for patients who failed to daclatasvir and asunaprevir combination therapyPatients with chronic hepatitis C, who failed to DCV/ASV therapyJPRN-UMIN000021790St. Marianna University School of Medicine20
已完成
不适用
Effects of Ribavirin and dexamethasone on clinical outcome of Crimean-Congo Hemorrhagic FeverCrimean-Congo Hemorrhagic Fever.Central Asian haemorrhagic feverIRCT2015120525378N1Vice chancellor for research,Zahedan University of Medical Sciences50
进行中（未招募）
不适用
Efecto del tratamiento con dosis altas de Ribavirina frente a dosis estándar en pacientes infectados con el virus de la Hepatitis C Crónica genotipo 3 y carga viral alta sin respuesta en semana 4. - DARGEN-3EUCTR2008-000328-16-ESFundacion Hospital Alcorcon
尚未招募
1 期
Effect of Rivaroxaban in ThrombosisIRCT20231021059793N1Tehran University of Medical Sciences20
已完成
不适用
A study of interferon beta/ ribavirin plus non-activated vitamin D combination therapy for chronic hepatitis C and decompensated cirrhosis patients.JPRN-UMIN000010812Saitama Medical University60